$2,670,000 of UNITEDHEALTH GROUP INC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Data Privacy Paperless/Digital Healthcare Communications Value-Based Care No Surprises Act Healthcare Modernization Policies Health Care Affordability AI/Technology Prior Authorization Cyber Security Medicaid and Commercial Market Coverage Policy Medicare Advantage Program Medicare Modernization Proposals Drug Pricing PBM and Drug Pricing Reforms Veterans Health Issues Health Savings Health Equity"
You can find more data on corporate lobbying on Quiver Quantitative.
UNH Congressional Stock Trading
Members of Congress have traded $UNH stock 14 times in the past 6 months. Of those trades, 7 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $UNH stock by members of Congress over the last 6 months:
- REPRESENTATIVE RICHARD MCCORMICK has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/19, 11/05 and 0 sales.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 2 purchases worth up to $65,000 on 03/13, 12/19 and 2 sales worth up to $65,000 on 02/10, 11/12.
- SENATOR MARKWAYNE MULLIN purchased up to $100,000 on 02/25.
- REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 02/05.
- REPRESENTATIVE KEVIN HERN sold up to $500,000 on 12/23.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
UNH Hedge Fund Activity
We have seen 1,261 institutional investors add shares of UNH stock to their portfolio, and 1,770 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 20,260,160 shares (-73.6%) from their portfolio in Q4 2025, for an estimated $6,688,081,417
- CAPITAL RESEARCH GLOBAL INVESTORS removed 6,780,251 shares (-52.0%) from their portfolio in Q4 2025, for an estimated $2,238,228,657
- CARDANO RISK MANAGEMENT B.V. removed 2,264,606 shares (-89.7%) from their portfolio in Q1 2026, for an estimated $608,839,323
- CITADEL ADVISORS LLC added 2,079,416 shares (+244.9%) to their portfolio in Q4 2025, for an estimated $686,436,015
- UBS GROUP AG removed 1,839,868 shares (-40.3%) from their portfolio in Q4 2025, for an estimated $607,358,825
- ROCKEFELLER CAPITAL MANAGEMENT L.P. added 1,568,099 shares (+532.9%) to their portfolio in Q4 2025, for an estimated $517,645,160
- AMUNDI added 1,544,066 shares (+26.6%) to their portfolio in Q4 2025, for an estimated $509,711,627
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
UNH Analyst Ratings
Wall Street analysts have issued reports on $UNH in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 02/05/2026
- Truist Securities issued a "Buy" rating on 02/02/2026
- Barclays issued a "Overweight" rating on 01/30/2026
- Wells Fargo issued a "Overweight" rating on 01/30/2026
- Jefferies issued a "Buy" rating on 01/28/2026
- Leerink Partners issued a "Outperform" rating on 01/28/2026
- Bernstein issued a "Outperform" rating on 10/30/2025
To track analyst ratings and price targets for UNH, check out Quiver Quantitative's $UNH forecast page.
UNH Price Targets
Multiple analysts have issued price targets for $UNH recently. We have seen 16 analysts offer price targets for $UNH in the last 6 months, with a median target of $371.5.
Here are some recent targets:
- David Windley from Jefferies set a target price of $373.0 on 04/20/2026
- Lance Wilkes from Bernstein set a target price of $411.0 on 04/07/2026
- John Ransom from Raymond James set a target price of $330.0 on 04/01/2026
- Ann Hynes from Mizuho set a target price of $350.0 on 02/05/2026
- David Macdonald from Truist Securities set a target price of $370.0 on 02/02/2026
- Lisa Gill from JP Morgan set a target price of $389.0 on 02/02/2026
- Stephen Baxter from Wells Fargo set a target price of $370.0 on 01/30/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
